U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents

Published on 22 May 2023 on MSN News

By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in...

Read the rest of the article

Start tracking your investments with Statfolio

On Wednesday, TD (TSX:TD) Cowen showed confidence in Regeneron Pharmaceuticals Inc (NASDAQ:REGN),...

Investing.com 24 Apr 2024

Over the past year, many Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold a significan...

Simply Wall St. via Yahoo Finance 19 Apr 2024

Cathie Wood's ARK buys its Bitcoin and Ethereum ETFs, and more Tesla stock

Investing.com 19 Apr 2024

Regeneron (REGN) stock remains a buying opportunity, RBC Capital Markets said, after the Departme...

Seeking Alpha 11 Apr 2024

The DOJ has filed a complaint against Regeneron (REGN) alleging the drugmaker fraudulently inflat...

Seeking Alpha 10 Apr 2024

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) faced a blow in early trading after being hit with fr...

Proactive Investors 10 Apr 2024

Key Insights Regeneron Pharmaceuticals' estimated fair value is US$1,774 based on 2 Stage Free Ca...

Simply Wall St. via Yahoo Finance 10 Apr 2024

Dupixent from Sanofi and Regeneron Pharmaceuticals is expected to gain approval for COPD, which...

Seeking Alpha 1 Apr 2024

Most readers would already know that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased by ...

Simply Wall St. via Yahoo Finance 30 Mar 2024

In today’s Petri Dish we’ll cover why Replimune Group is shaking up its C-suite, how BioNTech is...

The Business Journals 28 Mar 2024